Table 2 RCC patient and healthy donor demographics
Patient | Age/sex | Stage | Grade | Adjuvant treatment | Healthy donor | Age/sex |
|---|---|---|---|---|---|---|
1 | 42 F | T3aN0M0 | 2 | – | 1 | 41 M |
2 | 53 M | T1N0M0 | 3 | – | 2 | 50 M |
3 | 60 M | T3aN0M0 | 2 | – | 3 | 54 M |
4 | 54 F | T3aN0M0 | 2 | – | 4 | 52 F |
5 | 68 M | T3aN0M0 | 3 | – | 5 | 67 M |
6 | 65 F | T3aN0M0 | 3 | – | 6 | 60 F |
7 | 65 F | T3bN0M0 | 1 | – | 7 | 61 F |
8 | 54 F | T3aN0M0 | 3 | – | 8 | 50 F |
9 | 67 M | T3aN0M0 | 2 | – | 9 | 58 M |
10 | 74 M | T3bN0M0 | 2 | – | 10 | 72 M |
11 | 53 M | T1bN0M0 | 1 | – | 11 | 51 M |
12 | 57 M | T1aN0M0 | 2 | – | 12 | 57 M |
13 | 63 F | T1N0M0 | 1 | – | 13 | 53 F |
14 | 80 F | T1bN0M0 | 2 | – | 14 | 72 F |
15 | 65 F | T1aN0M0 | 2 | – | 15 | 61 F |
16 | 72 M | T1N1M0 | 2 | – |  |  |
17 | 64 F | T2N1M0 | 2 | – |  |  |
18 | 43 M | T1aN1M0 | 3 | – |  |  |
19 | 62 M | T1bN0M0 | 1 | – |  |  |
20 | 33 M | T3bN0M0 | 2 | – |  |  |
21 | 69 M | T1aN0M0 | 2 | – |  |  |
22 | 72 M | T3bN0M0 | 2 | – |  |  |
23 | 53 F | T2N0M0 | 2 | – |  |  |
24 | 61 F | T3aN0M0 | 3 | – |  |  |
25 | 60 M | T3bN0M0 | 2 | – |  |  |